• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2021 Apr 6;27(6).
doi: 10.3201/eid2706.210728. Online ahead of print.
Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan

Yasuhiro Yamada, Kaoru Fujinami, Tadashi Eguchi, Hiroshi Takefuji, Nobuaki Mori

Abstract

In Japan, a 51-year-old man had minimally symptomatic severe acute respiratory syndrome coronavirus 2 infection. Multisystem inflammatory syndrome was diagnosed ?5 weeks later; characteristics included severe inflammation, cardiac dysfunction, and IgG positivity. Clinicians should obtain detailed history and examine IgG levels for cases of inflammatory disease with unexplained cardiac decompensation.

Keywords: COVID-19; Japan; SARS-CoV-2; coronavirus disease; multisystem inflammatory syndrome; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom